Found 0 matching trials
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer PHASE3 PURPOSE: This randomized phase III trial is studying cetuximab and/or bevac...
Show More Location
Providence Cancer Center at Providence Hospital
Learn More & Join Trial
CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio-marker Driven Cetuximab-based Treatment Regimen PHASE2 This clinical program aims to evaluate the activity and efficacy of cetuxim...
Show More Status
Active Not Recruiting
Location
A.O.U. Ospedali Riuniti
Learn More & Join Trial
Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer PHASE1 The primary objective is to determine the dose of aflibercept to be further...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) PHASE1 The purpose of this study is to evaluate the safety and preliminary clinica...
Show More Location
Sarah Cannon Research Institute at Health One
Learn More & Join Trial
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer PHASE1 The purpose of the Phase Ib portion is to find out the highest dose of stud...
Show More Location
Multiple Locations
Learn More & Join Trial
Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM PHASE2 This prospective study aims to investigate the efficacy and safety of perit...
Show More Location
Sixth Affiliated Hospital, Sun Yat-sen University
Learn More & Join Trial
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors PHASE1 Immune therapies work with the body's immune system to treat a number of ca...
Show More Location
Providence Medical Foundation
Learn More & Join Trial
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan PHASE2 Primary Objective:
To assess efficacy aflibercept + 5-fluorouracil (5-FU)/...
Show More Location
Investigational Site Number 392011
Learn More & Join Trial
Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) PHASE2 This will be a randomized, open-label, multicenter, Phase II study with pri...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation PHASE3 The aim of this study is to compare progression free survival (PFS) in trea...
Show More Location
Ironwood Cancer and Research Centers Scottsdale
Learn More & Join Trial